US Patent

US10918816 — Compliance monitoring module for a breath-actuated inhaler

Formulation · Assigned to Norton Waterford Ltd · Expires 2035-12-14 · 10y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a compliance monitoring module for a breath-actuated inhaler that tracks user inhalation of medication.

USPTO Abstract

A compliance monitoring module for a breath-actuated inhaler comprising: a miniature pressure sensor, a sensor port of said sensor being pneumatically coupled to a flow channel through which a user can inhale; a processor configured to: receive a signal originating from a dosing mechanism of the inhaler indicating that medication has been released; receive data from a sensing element of the sensor; and based on said signal from said dosing mechanism and said data from said sensing element, make a determination that inhalation of a breath containing medication through said flow channel complies with one or more predetermined requirements for successful dosing; and a transmitter configured to, responsive to said determination, issue a dosing report.

Drugs covered by this patent

Patent Metadata

Patent number
US10918816
Jurisdiction
US
Classification
Formulation
Expires
2035-12-14
Drug substance claim
No
Drug product claim
Yes
Assignee
Norton Waterford Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.